Rocket Pharmaceuticals Inc

11 de set. de 2026, 22:36 UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of declines over the past four sessions and remaining below its 20-day moving average.

8 de set. de 2026, 20:07 UTC

Rocket Pharmaceuticals is declining today, pulling back from an early high amid notable session losses. The stock remains above its 20-day moving average.

4 de set. de 2026, 22:14 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours following a weak session, despite trading above the 20-day moving average.

3 de set. de 2026, 20:07 UTC

Rocket Pharmaceuticals Inc shares are declining amid broader market pressure, with no specific news identified. Earlier, the stock pulled back from a session high.

2 de set. de 2026, 22:01 UTC

Rocket Pharmaceuticals shares lower in after-market trading, declining since Wednesday's close. This follows a weaker-than-expected job growth report from ADP.

1 de set. de 2026, 21:02 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours, amid broader economic concerns and rising crude oil prices linked to geopolitical tensions.

31 de ago. de 2026, 20:03 UTC

Rocket Pharmaceuticals is lower today amid broader market pressures and concerns over inflation and potential Federal Reserve tightening following comments from Warsh at Jackson Hole.

28 de ago. de 2026, 23:26 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market trading. Broader market expectations for a rate hike may be influencing investor sentiment.

26 de ago. de 2026, 20:08 UTC

Rocket Pharmaceuticals is lower as biotechnology stocks face significant pressure, influencing its price action despite remaining above the 20-day moving average.

25 de ago. de 2026, 23:16 UTC

Rocket Pharmaceuticals shares are lower in after-market hours, following unusual trading activity and a broader market decline influenced by falling crude oil prices.

24 de ago. de 2026, 20:06 UTC

Rocket Pharmaceuticals shares are higher, reflecting broader market gains. The market peaked early, though no specific company news was identified for the price movement.

21 de ago. de 2026, 19:51 UTC

Rocket Pharmaceuticals Inc is rising during Friday's session, supported by strength in the biotechnology sector. The stock remains above its 20-day moving average.

20 de ago. de 2026, 20:06 UTC

Rocket Pharmaceuticals Inc is lower today, reflecting broader pressures in the biotechnology sector. The overall market is also trending downwards.

19 de ago. de 2026, 20:02 UTC

Rocket Pharmaceuticals Inc shares are sharply higher today, reflecting strong momentum amid notable gains in biotechnology stocks and positive sector dynamics.

18 de ago. de 2026, 19:46 UTC

Rocket Pharmaceuticals shares are lower today, reflecting a decline since Monday. Broader market trends and rising Treasury yields may be influencing investor sentiment.

17 de ago. de 2026, 23:46 UTC

Rocket Pharmaceuticals Inc shares are higher in after-market trading, reflecting positive performance despite broader market pressures and no specific company news identified.

14 de ago. de 2026, 22:01 UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, with no specific news identified. Broader market concerns may be influencing the decline.

13 de ago. de 2026, 19:56 UTC

Rocket Pharmaceuticals Inc shares are lower today, continuing a recent downward trend amid rising U.S. unemployment claims, with no specific company news identified.

12 de ago. de 2026, 19:16 UTC

Rocket Pharmaceuticals Inc shares are lower today, with no specific news driving the decline. Earlier, the stock reached a session high before falling.

11 de ago. de 2026, 20:02 UTC

Rocket Pharmaceuticals shares are lower after Wedbush cut its price target to $15, reflecting concerns over mixed second-quarter earnings results.

10 de ago. de 2026, 23:26 UTC

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

8 de ago. de 2026, 00:01 UTC

Rocket Pharmaceuticals Inc. shares are higher in after-market trading, advancing modestly since Friday's close and remaining above its 20-day moving average.

7 de ago. de 2026, 23:01 UTC

Rocket Pharmaceuticals Inc. shares have shown little change in after-market trading, remaining within a narrow band since Friday's close.

6 de ago. de 2026, 23:06 UTC

Rocket Pharmaceuticals Inc is trading higher in after-market hours, remaining above its 20-day moving average amid no specific news to explain the movement.

5 de ago. de 2026, 20:02 UTC

Rocket Pharmaceuticals is rising Wednesday, driven by a strong Biotechnology sub-sector. The stock remains above its 20-day moving average during the session.

4 de ago. de 2026, 19:26 UTC

Rocket Pharmaceuticals shares rise as Wedbush maintains Outperform rating with a $16 price target. The company also reported promising safety results in its Phase 2 trial.

3 de ago. de 2026, 22:01 UTC

Rocket Pharmaceuticals shares are lower in after-market trading despite a positive clinical safety update on its Phase 2 trial for RP-A501.

31 de jul. de 2026, 22:01 UTC

Rocket Pharmaceuticals shares declined in after-hours trading, continuing a downward trend since Friday's close. The stock remains below its 20-day moving average.

30 de jul. de 2026, 21:51 UTC

Rocket Pharmaceuticals is lower in after-market hours, reflecting declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

29 de jul. de 2026, 20:52 UTC

Rocket Pharmaceuticals shares are lower in after-market hours amid a broader market decline driven by rising crude oil prices and geopolitical tensions.